{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T12:49:00Z","timestamp":1773751740206,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.diagmicrobio.2011.11.016","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T12:49:41Z","timestamp":1329223781000},"page":"332-339","source":"Crossref","is-referenced-by-count":26,"title":["Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains"],"prefix":"10.1016","volume":"72","author":[{"given":"Dayane C.","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena A.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Walderez","family":"Szeszs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas X.","family":"Bonfietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulcilena","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia S.C.","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0005","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/AAC.44.6.1544-1548.2000","article-title":"Correlation of fluconazole MICs with clinical outcome in cryptococcal infection","volume":"44","author":"Aller","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1099\/00221287-147-4-891","article-title":"Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans","volume":"147","author":"Boekhout","year":"2001","journal-title":"Microbiology"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0015","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/JCM.34.4.912-917.1996","article-title":"Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group","volume":"34","author":"Brandt","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0732-8893(00)00173-5","article-title":"A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time\u2013kill methodology","volume":"38","author":"Burgess","year":"2000","journal-title":"Diag. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2011.05.009","article-title":"Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals","author":"Byrnes","year":"2011","journal-title":"Microbes Infect."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0030","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/EC.4.8.1403-1409.2005","article-title":"Clonality and re-combination in genetically differentiated subgroups of Cryptococcus gattii","volume":"4","author":"Campbell","year":"2005","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0035","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/AAC.48.7.2477-2482.2004","article-title":"Patterns of amphotericin B killing kinetics against seven Candida species","volume":"48","author":"Cant\u00f3n","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0732-8893(02)00525-4","article-title":"Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species","volume":"45","author":"Cant\u00f3n","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1567-1356(03)00038-2","article-title":"Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul","volume":"3","author":"Casali","year":"2003","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and host- and variety dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group","volume":"31","author":"Chen","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0732-8893(99)00137-6","article-title":"Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan","volume":"36","author":"Chen","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0060","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1128\/IAI.00628-09","article-title":"Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans","volume":"77","author":"Cheng","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0065","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/JCM.01271-10","article-title":"In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype","volume":"48","author":"Chong","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0070","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1099\/jmm.0.029025-0","article-title":"In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var grubii and Cryptococcus gattii serotype B from north western India","volume":"60","author":"Chowdhary","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0075","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1128\/AAC.01520-05","article-title":"Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis","volume":"50","author":"Dannanoui","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1469-0691.2009.02997.x","article-title":"Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories","volume":"16","author":"Dannaoui","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0085","first-page":"36","article-title":"In vitro antifungal susceptibility of clinical isolates of Cryptococcus neoformans var. neoformans and C. neoformans var. gattii","volume":"16","author":"De Bedout","year":"1999","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/mmy.38.s1.173.182","article-title":"Epidemiology: surveillance of fungal infections","volume":"38","author":"Ellis","year":"2000","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0095","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.44.4.1108-1111.2000","article-title":"Postantifungal effects of echinocandin, azole and polyene antifungal agents Candida albicans and Cryptococcus neoformans","volume":"44","author":"Ernst","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1567-1364.2006.00055.x","article-title":"Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia","volume":"6","author":"Escand\u00f3n","year":"2006","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0105","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1567-1364.2008.00422.x","article-title":"Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients","volume":"8","author":"Feng","year":"2008","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0110","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1469-0691.2008.02021.x","article-title":"In vitro susceptibility of Cryptococcus gattii clinical isolates","volume":"14","author":"Gomez-Lopez","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0115","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1128\/AAC.00746-10","article-title":"In vitro antifungal susceptibilities and AFLP genotyping of a worldwide collection of 350 clinical, veterinary and environmental Cryptococcus gattii isolates","volume":"54","author":"Hagen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/13693780310001644743","article-title":"Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro","volume":"42","author":"Igreja","year":"2004","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/JCM.01505-09","article-title":"Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii from the Pacific Northwest of the United States","volume":"48","author":"Iqbal","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0732-8893(01)00297-8","article-title":"Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time\u2013kill methodology","volume":"41","author":"Keele","year":"2001","journal-title":"Diag. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/jac\/dkm192","article-title":"Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India","volume":"60","author":"Khan","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0140","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1073\/pnas.0402981101","article-title":"A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)","volume":"101","author":"Kidd","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0145","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/EC.4.10.1629-1638.2005","article-title":"Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas","volume":"4","author":"Kidd","year":"2005","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0150","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1128\/AAC.44.7.1917-1920.2000","article-title":"Evaluation of voriconazole pharmacodynamics using time\u2013kill methodology","volume":"44","author":"Klepser","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0732-8893(97)00144-2","article-title":"Growth medium effect on the antifungal activity of LY 303366","volume":"29","author":"Klepser","year":"1997","journal-title":"Diag. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0160","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/JCM.15.3.535-537.1982","article-title":"Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C)","volume":"15","author":"Kwon-Chung","year":"1982","journal-title":"J. Clin. Microbiol"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0165","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1128\/AEM.69.4.2080-2086.2003","article-title":"PCR-Restriction fragment polymorphism analysis of the phospholipase B (PLB1) gene for subtyping of Cryptococcus neoformans isolates","volume":"69","author":"Latouche","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3201\/eid1301.060827","article-title":"Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA","volume":"13","author":"MacDougall","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/S0036-46652007000100008","article-title":"Genotyping, serotyping and determination of mating-type of Cryptococcus neoformans clinical isolates from S\u00e3o Paulo State, Brazil","volume":"49","author":"Matsumoto","year":"2007","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0180","first-page":"11","article-title":"Genotyping of the Cryptococcus neoformans\/C. gattii species complex","volume":"41","author":"Meyer","year":"2010","journal-title":"Aust. Biochem."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid0902.020246","article-title":"Molecular typing of Ibero American Cryptococcus neoformans isolates","volume":"9","author":"Meyer","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0190","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/13693780902953886","article-title":"Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii","volume":"47","author":"Meyer","year":"2009","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0195","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/clinids\/20.3.611","article-title":"Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome","volume":"20","author":"Mitchell","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0200","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/13693780903358317","article-title":"Genotype and mating type distribution within clinical Cryptococcus neoformans and Cryptococcus gattii isolates from patients with cryptococcal meningitis in Uberaba, Minas Gerais, Brazil","volume":"48","author":"Mora","year":"2010","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/13693780400029528","article-title":"Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole","volume":"43","author":"Morera-Lopez","year":"2005","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0210","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1086\/507897","article-title":"Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002\u20132004","volume":"43","author":"Morgan","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diagmicrobio.2004.08.013","article-title":"Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time\u2013kill methodologies","volume":"51","author":"Nooney","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0220","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.diagmicrobio.2009.02.007","article-title":"Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time\u2013kill methodology","volume":"64","author":"Papparlado","year":"2009","journal-title":"Diag. Microbiol. Infec. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0230","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","article-title":"Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)","volume":"43","author":"Pfaller","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0235","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/AAC.39.4.906","article-title":"Detection of amphotericin B-resistant Candida isolates in a broth based system","volume":"39","author":"Rex","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0240","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1590\/S0036-46652008000600001","article-title":"Molecular characterization of environmental Cryptococcus neoformans isolated in Vitoria, ES, Brazil","volume":"50","author":"Ribeiro","year":"2008","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0245","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jac\/45.2.239","article-title":"In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy","volume":"45","author":"Rodero","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0250","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/mmy.38.3.201.207","article-title":"Time\u2013kill curves for Cryptococcus neoformans isolated from patients with AIDS","volume":"38","author":"Rodero","year":"2000","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0255","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0260","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1590\/S0074-02762008000800012","article-title":"Primary endemic Cryptococcosis gattii by molecular type VGII in the state of Para, Brazil","volume":"103","author":"Santos","year":"2008","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0265","doi-asserted-by":"crossref","first-page":"e1000848","DOI":"10.1371\/journal.ppat.1000848","article-title":"Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes","volume":"6","author":"Sionov","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/mmy.39.2.155.168","article-title":"Cryptococcus neoformans variety gattii","volume":"39","author":"Sorrell","year":"2001","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/21.1.28","article-title":"Clinical and host differences between infections with the two varieties of Cryptococcus neoformans","volume":"21","author":"Speed","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0280","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1439-0507.2006.01242.x","article-title":"In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs","volume":"49","author":"Tay","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0285","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01216-08","article-title":"Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans","volume":"53","author":"Thompson","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0290","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jac\/dkn132","article-title":"MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii","volume":"62","author":"Torres-Rodr\u00edguez","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0295","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1128\/JCM.42.10.4815-4817.2004","article-title":"In vitro antifungal susceptibility of Cryptococcus gattii","volume":"42","author":"Trilles","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0300","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1590\/S0074-02762008000500008","article-title":"Regional pattern of the molecular type of Cryptococcus neoformans and Cryptococcus gattii in Brazil","volume":"5","author":"Trilles","year":"2008","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0305","article-title":"Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans\/C. gattii species complex","author":"Trilles","year":"2011","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0310","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1128\/AAC.00153-10","article-title":"Heteroresistance of Cryptococcus gattii to fluconazole","volume":"54","author":"Varma","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0315","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin. Microbial. Rev."},{"key":"10.1016\/j.diagmicrobio.2011.11.016_bb0320","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/AAC.01631-10","article-title":"A process analysis of variables for standardization of antifungal susceptibility testing of non-fermentative yeasts","volume":"55","author":"Zaragoza","year":"2011","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889311004925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889311004925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T11:40:56Z","timestamp":1593690056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889311004925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0732889311004925"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.11.016","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}